HAIM
Hunter Associates Investment Management Portfolio holdings
AUM
$674M
This Quarter Return
-5.38%
1 Year Return
+15.27%
3 Year Return
+56.48%
5 Year Return
+107.92%
10 Year Return
+280.73%
AUM
$311M
AUM Growth
+$311M
(-11%)
Cap. Flow
-$15.4M
Cap. Flow
% of AUM
-4.96%
Top 10 Holdings %
Top 10 Hldgs %
46.47%
Holding
160
New
3
Increased
17
Reduced
41
Closed
13
Top Buys
| 1 |
Shell
SHEL
|
$745K |
| 2 |
Bristol-Myers Squibb
BMY
|
$664K |
| 3 |
L3Harris
LHX
|
$447K |
| 4 |
Exxon Mobil
XOM
|
$421K |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
$227K |
Top Sells
| 1 |
Microsoft
MSFT
|
$1.8M |
| 2 |
Thermo Fisher Scientific
TMO
|
$1.42M |
| 3 |
Accenture
ACN
|
$1.28M |
| 4 |
Apple
AAPL
|
$1.16M |
| 5 |
Nasdaq
NDAQ
|
$811K |
Sector Composition
| 1 | Technology | 32.32% |
| 2 | Healthcare | 20.74% |
| 3 | Industrials | 11.79% |
| 4 | Financials | 10.59% |
| 5 | Consumer Staples | 5.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Microsoft
MSFT
$3.77T
| $32M | 10.29% | 103,696 -5,847 | -5% | -$1.8M |
|
|
2
Apple
AAPL
$3.45T
| $31.8M | 10.22% | 181,859 -6,646 | -4% | -$1.16M |
|
3
T Rowe Price
TROW
$23.6B
| $15.3M | 4.94% | 101,422 -1,125 | -1% | -$170K |
|
4
Omega Flex
OFLX
$356M
| $10.5M | 3.38% | 80,860 | – | – |
|
5
Amgen
AMGN
$155B
| $10.2M | 3.27% | 42,055 -325 | -0.8% | -$78.6K |
|
|
6
Accenture
ACN
$162B
| $9.69M | 3.12% | 28,736 -3,800 | -12% | -$1.28M |
|
7
United Parcel Service
UPS
$74.1B
| $9.67M | 3.11% | 45,100 -100 | -0.2% | -$21.4K |
|
8
ResMed
RMD
$40.2B
| $8.83M | 2.84% | 36,429 -2,800 | -7% | -$679K |
|
9
DMC Global
BOOM
$138M
| $8.63M | 2.78% | 282,800 +2,500 | +0.9% | +$76.2K |
|
10
Procter & Gamble
PG
$368B
| $7.79M | 2.51% | 51,006 -1,500 | -3% | -$229K |
|
11
PPG Industries
PPG
$25.1B
| $7.13M | 2.3% | 54,397 +118 | +0.2% | +$15.5K |
|
12
Cisco
CSCO
$274B
| $7.09M | 2.28% | 127,180 | – | – |
|
13
Pfizer
PFE
$141B
| $6.09M | 1.96% | 117,634 | – | – |
|
14
Johnson & Johnson
JNJ
$427B
| $5.59M | 1.8% | 31,510 -1,250 | -4% | -$222K |
|
15
Texas Pacific Land
TPL
$21.5B
| $5.41M | 1.74% | 4,000 -200 | -5% | -$270K |
|
16
Eli Lilly
LLY
$657B
| $5.28M | 1.7% | 18,428 | – | – |
|
17
SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.44B
| $5.18M | 1.67% | 109,348 | – | – |
|
18
Fiserv
FI
$75.1B
| $4.54M | 1.46% | 44,792 | – | – |
|
19
Stryker
SYK
$150B
| $3.95M | 1.27% | 14,788 | – | – |
|
20
Morgan Stanley
MS
$240B
| $3.45M | 1.11% | 39,464 -2,459 | -6% | -$215K |
|
21
Lindblad Expeditions
LIND
$799M
| $3.2M | 1.03% | 212,000 -25,000 | -11% | -$377K |
|
22
AbbVie
ABBV
$372B
| $3.1M | 1% | 19,100 -500 | -3% | -$81K |
|
|
23
Exxon Mobil
XOM
$487B
| $3.06M | 0.99% | 37,100 +5,100 | +16% | +$421K |
|
|
24
Bristol-Myers Squibb
BMY
$96B
| $3.05M | 0.98% | 41,796 +9,089 | +28% | +$664K |
|
|
25
Thermo Fisher Scientific
TMO
$186B
| $3.04M | 0.98% | 5,150 -2,400 | -32% | -$1.42M |
|